If you live in the UAE and are a citizen, the government likely already has a copy of your genetic profile, or is about to. The national sequencing program has mapped 815.000 genomes across a population of approximately one million people. The infrastructure is impressive: fifteen sequencers costing $1,25 million each, cutting-edge laboratories, and a supercomputer called Artemis to process mountains of data.
The official goal is noble: personalized medicine, prevention, early diagnosis. The problem is that all those terabytes of genetic information end up in a state database. Forever. With access rules that define DNA as a "national priority": a curious way of understanding privacy.
Fifteen machines, a million destinies
Albarah El-Khani is the mind behind the program's operations center in Abu Dhabi. When accompanies visitors through the 4.800-square-meter structure, he stops in front of a room that contains something you are unlikely to find elsewhere: fifteen NovaSeq X Plus, half-ton genomic sequencers. Each machine can process 128 DNA samples simultaneously, producing up to 16 terabytes of data per cycle. It's like having 500 MacBooks filling up with genetic information every time you hit "send."
THEEmirates Genome Programme he left in 2019 as a collaboration between the Department of Health of Abu Dhabi and Group 42, a local technology company. Citizens can donate (voluntarily, it must be said) a blood sample at one of the many collection centers scattered across the emirates. Six weeks later, their complete genome is ready. All for free, of course. When something is free, the product is usually you. Or your DNA.
From newborn to database
In August 2025 the program took a leap forward: now also includes newbornsYou're born in the Emirates to Emirati parents, and your genetic profile is automatically entered into the system. The idea is to detect genetic diseases before they manifest, offer preventive screening, and personalize treatments. It all makes sense on paper. In practice, it means the state knows your biological code before you can even walk.
Secondo a study published in September 2025 su medRxiv, the program analyzed 43.608 genomes, identifying over 5 million new genetic variants specific to the Emirati population.
Researchers have found correlations with cardiovascular disease, type 2 diabetes, and cancer predisposition. This information is valuable for medical research. Highly sensitive information if it ends up in the wrong hands.
The missing genetic map
There's a real problem that the Emirati program is addressing: most global genomic databases are based on European or North American populations. Middle Eastern genetic variants are historically underrepresented. This means that diagnoses and therapies developed based on Western data may not work as well on Arab patients. The Emirates are filling this scientific gap. as the Human Genome Project did twenty years ago for the entire species.
Other countries in the region have similar programs. Qatar has sequenced over 25.000 genomes. Saudi Arabia It's aiming for 100.000 by the end of this year. However, no one has the scale and infrastructure of the Emirates. If it's a race, Abu Dhabi is winning hands down.
Population genetic profiling: science is not the problem
Mass genomic sequencing works. Personalized medicine is the future. Startups like Nucleus are already selling complete genomic analyses for $400., demonstrating that the technology is mature and accessible. The problem isn't technical, it's political.
In the Emirates, genetic data is considered “national priority”This means that, despite promises of confidentiality and informed consent, the state has a strategic interest in that information. As the 23andMe case demonstratedWhen an entity controls massive genetic databases, the temptation to use them for purposes other than those stated is high. And if the entity in question is a government, things get more complicated.
UAE data protection laws are opaque. There are no regulations comparable to the European GDPR. The concept of individual ownership of one's DNA is, let's say, interpretable. In theory, citizens can refuse to participate. In practice, when a state invests billions in genomic infrastructure and presents it as free healthcare progress, refusing becomes a complicated choice.
Medicine or surveillance?
Who decides how this data is used, and with what safeguards? In the United States. Police have already used newborn DNA samples for criminal investigations of family members. In China, the government has collected genetic profiles of ethnic minorities for social control purposes.
The Emirates swear that their program serves only public health purposes. Perhaps that's true. But building a national genetic database without regulatory transparency, independent oversight, and laws that define DNA as "strategic interest" isn't exactly reassuring.
The future of medicine, certainly, will be personalized: the future of privacy, however, may not be personalized at all.
